Pendal Group LTD Edwards Lifesciences Corp Transaction History

Pendal Group LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$106.37 - $130.68 $190,508 - $234,047	-1,791 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$102.91 - $122.75 $184,311 - $219,845	1,791 New	1,791 $203,000
Q1 2021 May 03, 2021	SELL	$78.68 - $90.67 $188,045 - $216,701	-2,390 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$71.69 - $91.23 $171,339 - $218,039	2,390 New	2,390 $218,000
Q3 2020 Nov 02, 2020	SELL	$67.19 - $87.44 $448,896 - $584,186	-6,681 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$57.54 - $76.95 $43,787 - $58,558	-761 Reduced 10.23%	6,681 $462,000
Q1 2020 May 04, 2020	BUY	$52.41 - $81.0 $390,035 - $602,802	7,442 New	7,442 $467,000
Q4 2019 Feb 06, 2020	SELL	$71.7 - $82.09 $23,732 - $27,171	-331 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $224,719 - $275,394	-3,651 Reduced 91.69%	331 $24,000
Q2 2019 Aug 01, 2019	BUY	$55.74 - $64.41 $65,215 - $75,359	1,170 Added 41.61%	3,982 $0
Q4 2018 Jan 30, 2019	BUY	$46.41 - $56.94 $130,504 - $160,115	2,812 New	2,812 $143,000

1,417

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.